About Index Trending news
Analyze
Pricing
CEL-SCI Corporation

CEL-SCI Corporation

Work at CEL-SCI Corporation? Add yourself to this profile

CEL-SCI Corporation

CEL-SCI's official Twitter handle. We are an immunotherapy company that focuses on unmet medical needs in oncology and infectious diseases.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$1,000,000
Venture capital
$4,400,000
Employees

Unknown size

Locations
HQ
$1,000,000 Post-IPO equity
bizjournals , sec

Vienna’s Cel-Sci Corp. (NYSE MKT: CVM) raises $1 million for head and neck cancer trial - Washington Business Journal